Bruker Stock Forecast for 2023 - 2025 - 2030
Updated on 04/27/2024
Bruker Stock Forecast and Price Target
Based on the current earnings figures, this year's price targets for Bruker were recently set by distinguished experts, with an average mark of $90.50. If it reached this goal, it would represent a potential upside of approximately 12.3% from the previous closing price in April, 2024. The high end is $105.00, and the low is $73.03. Although you may not be interested in BRKR stock, you should still be aware of its competitors.
12.30% Upside
Bruker Fair Value Forecast for 2023 - 2025 - 2030
Bruker's Price has decreased In the last four years, from $43.13 to $0.00 – a 100.00% drop. In the next year, analysts expect Fair Value to reach $90.74 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AVGO Stock Forecast | Broadcom | Outperform |
8
|
$1.29k | Buy/Sell | $1.21k | 19.74% |
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$571.73 | Buy/Sell | $591.94 | 7.57% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$245.80 | Buy/Sell | $260.33 | 9.85% |
| GE Stock Forecast | General Electric | Outperform |
8
|
$161.26 | Buy/Sell | $144.00 | 11.62% |
| 6501 Stock Forecast | Hitachi | Outperform |
4
|
¥13.24k | Buy/Sell | ¥11.29k | 7.29% |
Bruker Revenue Forecast for 2023 - 2025 - 2030
Bruker's Revenue has increased by 49.16% In the last three years, going from $1.99B to $2.96B. In the following year, 8 experts forecast Bruker's Revenue will decrease by 6.33%, to $2.78B. For the next seven years, the forecast is for Revenue to grow by 7.21%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MRK Stock Forecast | Merck KGaA | Outperform |
18
|
150.10€ | Buy/Sell | 190.06€ | 21.92% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$230.48 | Buy/Sell | $284.47 | 21.49% |
| BAS Stock Forecast | BASF | Outperform |
12
|
50.99€ | Buy/Sell | 49.50€ | 9.83% |
.jpg)
Bruker Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Bruker's Dividend per Share has grown, increasing from $0.16 to $0.20 – a growth of 25.00%. According to 3 major analysts, Bruker's Dividend per Share will fall by 35.00% in the next year, reaching $0.13. Professionals believe that By 2030, Bruker's Dividend per Share will fall to $0.19– a 3.07% decrease from its current value.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HO Stock Forecast | Thales | Outperform |
18
|
156.65€ | Buy/Sell | 154.47€ | 6.61% |
| 6503 Stock Forecast | Mitsubishi Electric | Outperform |
18
|
¥2.28k | Buy/Sell | ¥2.14k | 1.05% |
| 7011 Stock Forecast | Mitsubishi Heavy Industries | Outperform |
14
|
¥11.94k | Buy/Sell | ¥10.44k | -12.90% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ENTG Stock Forecast | Entegris | Outperform |
18
|
$128.54 | Buy/Sell | $116.12 | 14.36% |
| WAT Stock Forecast | Waters | Hold |
15
|
$308.35 | Buy/Sell | $323.50 | 7.02% |
| LH Stock Forecast | Laboratory Corp of America Hol... | Outperform |
11
|
$198.35 | Buy/Sell | $241.28 | 21.50% |
Bruker EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Bruker's EBITDA has grown from $346.50M to $557.80M – a 60.98% increase. Next year, analysts are expecting EBITDA to reach $651.71M – an increase of 16.84%. Over the next seven years, the forecast is for EBITDA to grow by 56.30%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| LDOS Stock Forecast | Leidos Holdings | Outperform |
9
|
$129.88 | Buy/Sell | $125.84 | 9.33% |
| 7733 Stock Forecast | Olympus | Outperform |
18
|
¥2.19k | Buy/Sell | ¥2.30k | 9.74% |
| DGX Stock Forecast | Quest Diagnostics | Outperform |
10
|
$135.42 | Buy/Sell | $141.17 | 7.07% |
Bruker EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Bruker's EBIT has grown by 66.44%, rising from $266.10M to $442.90M. For next year, analysts predict EBIT of $593.58M, which would mean an increase of 34.02%. Over the next seven years, experts predict that Bruker's EBIT will grow at a rate of 78.68%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BIM Stock Forecast | bioMérieux | Outperform |
18
|
99.50€ | Buy/Sell | 105.55€ | 14.32% |
| AES Stock Forecast | The AES | Outperform |
15
|
$17.13 | Buy/Sell | $21.61 | 25.51% |
| 5802 Stock Forecast | Sumitomo Electric Industries | Outperform |
16
|
¥2.14k | Buy/Sell | ¥1.94k | -6.43% |
Bruker EPS Price Prediction Forecast for 2023 - 2025 - 2030
Bruker's EPS has decreased In the last four years, from $1.35 to $0.00 – a 100.00% drop. In the next year, analysts expect EPS to reach $2.84 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ONTO Stock Forecast | Onto Innovation | Outperform |
16
|
$182.33 | Buy/Sell | $156.25 | 17.92% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$275.60 | Buy/Sell | $536.80 | 58.45% |
| MKSI Stock Forecast | MKS Instruments | Buy |
18
|
$116.27 | Buy/Sell | $96.71 | 11.81% |
.jpg)